Riskpilot← Back to searchSign inGet full accessVMOFIVE AS
ASActiveOrg 916538987Laughammaren 14, 4156 MosterøyBusiness and other management consultancy activities · NACE 7020Est. 20161 employees
Revenue 2024
NOK 332K
-22% vs 2023
EBITDA margin
-73.5%
-2235% vs 2023
Equity ratio
94.1%
Financial strength
Net profit 2024
NOK 696K
-44% vs 2023
| Revenue | NOK 332K | -22% |
| EBITDA | NOK -244K | -2235% |
| Net profit | NOK 696K | -44% |
| Total assets | NOK 8,2M | +9% |
| Equity | NOK 7,7M | +5% |
| Employees | 1 | — |
Legal name
VMOFIVE AS
Org number
916538987
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
11. januar 2016
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Konsulentvirksomhet innen økonomi samt investeringer i andre verdipapirer som faller innen samme kategori og andre tjenester og produkter som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender samt kjøp, salg og utleie av fast eiendom.
Address
Laughammaren 14, 4156 Mosterøy
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 681 | 519 | 489 | 425 | 332 |
| Staff expenses | −641 | −548 | −261 | −346 | −538 |
| EBITDA | −3 | −88 | 164 | 11 | −244 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | −88 | 164 | 11 | −244 |
| Net financials | 960 | 3 751 | 787 | 1 264 | 940 |
| Profit before tax | 957 | 3 662 | 951 | 1 275 | 696 |
| Tax | 6 | −0 | −0 | −0 | −0 |
| Net profit | 951 | 3 662 | 926 | 1 250 | 696 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 664 | 6 215 | 7 121 | 7 528 | 8 172 |
| Equity | 2 328 | 5 991 | 6 916 | 7 296 | 7 691 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 335 | 225 | 205 | 233 | 481 |
| Total debt | 335 | 225 | 205 | 233 | 481 |
EBITDA margin
-73.5%
This company
15.8%
Market median
-565% vs market
20202024
Equity ratio
94.1%
This company
38.2%
Market median
+146% vs market
20202024
Return on equity
9.0%
This company
18.4%
Market median
-51% vs market
20202024
Net profit margin
209.4%
This company
8.1%
Market median
+2485% vs market
20202024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ES Chief Executive Officer | Chief Executive Officer | 2016 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
VMOFIVE AS 
AMMEKLINIKKEN ASBoard members of VMOFIVE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Endre Schanche Rettedal | Chief Executive Officer | 0 companies |